Literature DB >> 10777151

Identification of all HIV type 1 group M subtypes in Senegal, a country with low and stable seroprevalence.

C Toure-Kane1, C Montavon, M A Faye, P M Gueye, P S Sow, I Ndoye, A Gaye-Diallo, E Delaporte, M Peeters, S Mboup.   

Abstract

A total of 343 HIV-1-positive samples obtained between June 1996 and March 1999 was genetically characterized in the envelope region by HMA and/or sequencing. The env subtype distribution was as follows: 290 (84.6%) A, 22 (6.5%) B, 16 (4.7%) C, 8 (2.5%) D, 1 (0.03%) E, 1 (0.03%) F1, 4 (1.2%) G, and 1 (0.03%) H. For 77 samples the p24 region from the gag gene was also sequenced, and for 9 (11.6%) the subtypes between env and gag were different. Phylogenetic tree analysis showed the predominance of AG-IBNG-like viruses among gag and env subtype A sequences. HMA is relatively simple and requires less sophisticated technical facilities compared with sequencing, and in Senegal 323 (94.2%) of the 343 samples could be identified by this technique. However, in the actual configuration of the assay, discrimination between the recombinant AG-IBNG-like recombinant viruses, which are predominant in Senegal, and the nonrecombinant subtype A viruses is not possible.

Entities:  

Mesh:

Year:  2000        PMID: 10777151     DOI: 10.1089/088922200309025

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  14 in total

1.  HIV-1 genetic diversity and drug resistance among Senegalese patients in the public health system.

Authors:  Moussa Thiam; Halimatou Diop-Ndiaye; Aminata Diaw Diouf; Nicole Vidal; Ousseynou Ndiaye; Ibrahima Ndiaye; Ndeye Fatou Ngom-Gueye; Sada Diallo; Oumy Diop Diongue; Makhtar Camara; Abdoulaye Seck; Souleymane Mboup; Coumba Toure-Kane
Journal:  J Clin Microbiol       Date:  2012-12-12       Impact factor: 5.948

2.  Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa.

Authors:  N Vidal; M Peeters; C Mulanga-Kabeya; N Nzilambi; D Robertson; W Ilunga; H Sema; K Tshimanga; B Bongo; E Delaporte
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Molecular epidemiology of human immunodeficiency virus type 1 sub-subtype A3 in Senegal from 1988 to 2001.

Authors:  Seema Thakore Meloni; Jean-Louis Sankalé; Donald J Hamel; Geoffrey Eisen; Aissatou Guéye-Ndiaye; Souleymane Mboup; Phyllis J Kanki
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3.

Authors:  Seema Thakore Meloni; Bohye Kim; Jean-Louis Sankalé; Donald J Hamel; Sodsai Tovanabutra; Souleymane Mboup; Francine E McCutchan; Phyllis J Kanki
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

5.  Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design.

Authors:  V Novitsky; N Rybak; M F McLane; P Gilbert; P Chigwedere; I Klein; S Gaolekwe; S Y Chang; T Peter; I Thior; T Ndung'u; F Vannberg; B T Foley; R Marlink; T H Lee; M Essex
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.

Authors:  N N Zheng; N B Kiviat; P S Sow; S E Hawes; A Wilson; H Diallo-Agne; C W Critchlow; G S Gottlieb; L Musey; M J McElrath
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

7.  Development, evaluation, and validation of an oligonucleotide probe hybridization assay to subtype human immunodeficiency virus type 1 circulating recombinant form CRF02_AG.

Authors:  Harr F Njai; Gert Van der Auwera; Chiambah A Ngong; Leo Heyndrickx; Souleymane Sawadago; Hilton Whittle; Phillipe Nyambi; Robert Colebunders; Guido van der Groen; Wouter Janssens
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.

Authors:  Natalie N Zheng; M Juliana McElrath; Papa-Salif Sow; Stephen E Hawes; Habibatou Diallo-Agne; Joshua E Stern; Fusheng Li; Andrew L Mesher; Akeliah D Robinson; Geoffrey S Gottlieb; Yunda Huang; Nancy B Kiviat
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

Review 9.  Evolution and diversity of HIV-1 in Africa--a review.

Authors:  Maria A Papathanasopoulos; Gillian M Hunt; Caroline T Tiemessen
Journal:  Virus Genes       Date:  2003       Impact factor: 2.332

10.  HIV-1 molecular epidemiology in Guinea-Bissau, West Africa: origin, demography and migrations.

Authors:  Joakim Esbjörnsson; Mattias Mild; Fredrik Månsson; Hans Norrgren; Patrik Medstrand
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.